Please login to the form below

Cello Health BioConsulting Appoints Senior Pharma Marketer As President

Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of Jim Hall as President.

Cello Health BioConsulting, the newly-formed strategic management consulting firm focusing on pharmaceuticals, biotechnology and medical device companies in the United States, has announced the appointment of Jim Hall as President.   

Jim joins Cello BioConsulting with over 25 years of experience, with the past 20 focused specifically on the life sciences industry.  During this time, Jim has gained an international reputation for his work and perspectives on commercial strategy, new business start-ups and business development.  He has also served on the boards of several successful start-ups. 

Prior to joining Cello Health BioConsulting Jim was a Senior VP leading Campbell Alliance’s Corporate Development Practice
  Previously, he was a Senior Partner at Oliver Wyman in the Health and Life Science Practice, before which he was the Global Leader of the Life Sciences Practice at PA Consulting.  Prior to PA, Jim led the Technology Practice at SRI Consulting (Stanford Research Institute), was the Vice President of Strategy and Technology for Sterling Drug Company and served as the Executive Director for the Brown University/State of Rhode Island’s Technology and Sciences Incubator.

Jon Bircher, Global CEO of Cello Health Consulting said, “We are delighted to appoint Jim as President of Cello Health BioConsulting.  He brings an unparalleled knowledge and understanding of the US and Global market, of great quality consulting and is the perfect person to lead the BioConsulting team helping expand Cello Health’s footprint in the United States and beyond.”  

Julia Ralston, CEO of Cello Health US, commented, “Jim’s long career in both the pharma industry and in senior consulting firms also make him a valued addition to our senior leadership in the US.  He will drive our expansion, not only working with our growing team of strong consultants as leading advisers to the bio-pharmaceutical and healthcare sector, but also contributing to our overarching Cello Health strategy.”  

Jim will be based at Cello Health’s BioConsulting Boston office.  Cello Health has offices in Boston, New York City, Philadelphia, Chicago and San Francisco.

28th September 2015

Share

Company Details

Cello Health

+44 (0)20 7812 8460

Contact Website

Address:
11-13 Charterhouse Buildings
London
EC1M 7AP
UK

Latest content on this profile

Cello Health Launches New Social Insight & Analytics Business
Cello Health Logic offers pharmaceutical companies the ability to make sense of healthcare social media conversations and deliver actionable insights.
Cello Health
Managing value: Why early asset development and commercialization is important
Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development.
Cello Health
Optimising market research data in rare disease
Helping to provide powerful insights into the burden of disease and the patient-caregiver experience.
Cello Health
Cello Health Communications Accelerates its Digital Offering with New Leadership Appointments
Rick Lang and Craig Lipski join the organization in senior digital roles
Cello Health
Duncan Munro joins Cello Health Insight as Joint Head of ‘IQ’ Practice
Supporting quantitative team’s continued growth, bringing specialist advanced analytics, methodological and technical expertise.
Cello Health
Maria Eletskaya joins Cello Health Insight
Bolstering senior team for expanding 'IQ' Quantitative practice
Cello Health